Aurinia Pharmaceuticals Inc. (AUPH) stock
AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3059% below fair value
$15.48−0.25 (-1.59%)
Close on Nov 16, 2026Market cap $2.07BP/E 6.8Yield –
Aurinia Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Aurinia Pharmaceuticals's EV/EBITDA was 11.6× on Nov 11, 2026, against 22.9× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.6× | −11.1 |
| 2025 | Dec 31, 2025 | 22.7× | – |
See a number that looks wrong?